{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:16:44Z","timestamp":1787318204383,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Unit Project of Chinese Academy of Medical Sciences","award":["2019-I2M-5-030"],"award-info":[{"award-number":["2019-I2M-5-030"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770645"],"award-info":[{"award-number":["81770645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Family Planning Commission of China","award":["2018260134"],"award-info":[{"award-number":["2018260134"]}]},{"name":"Key Research and Development Program of Zhejiang Province","award":["2020C03057"],"award-info":[{"award-number":["2020C03057"]}]},{"name":"Basic Public Interest Research Project of Zhejiang Province","award":["LGF18H030006"],"award-info":[{"award-number":["LGF18H030006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mesentericoportal vein (MPV) resection in pancreatic ductal adenocarcinoma (PDAC) surgery has become a common procedure. A few studies had described the use of falciform ligament (FL) for MPV reconstruction and received encouraging preliminary effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study was designed to explore the feasibility and efficacy of this technique compared with others.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who underwent pancreaticoduodenectomy (PD) with MPV resection for PDAC from 2009 to 2018 were enrolled. Medical records were retrospectively reviewed, MPV reconstructions using FL were distinguished and compared with other techniques.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>146 patients underwent MPV reconstruction, and 13 received FL venoplasty. Other reconstruction techniques included primary end-to-end anastomosis (primary, n\u2009=\u200930), lateral venorrhaphy (LV, n\u2009=\u200919), polytetrafluoroethylene conduit interposition (PTFE, n\u2009=\u200924), iliac artery (IA) allografts interposition (n\u2009=\u200947), and portal vein (PV) allografts interposition (n\u2009=\u200913). FL group holds the advantages of shortest operation time (p\u2009=\u20090.023), lowest blood loss (p\u2009=\u20090.109), and shortest postoperative hospital stay (p\u2009=\u20090.125). The grouped patency rates of FL, primary, LV, PTFE, IA, and PV were 100%, 90%, 68%, 54%, 68%, and 85% respectively. Comparison displayed that FL had the highest patency rate (p\u2009=\u20090.008) and lowest antiplatelet\/anticoagulation proportion (p\u2009=\u20090.000). Complications and long-term survival were similar among different techniques. The median survival time of patent group (24.0\u00a0months, 95% CI: 22.0\u201326.0) was much longer than that of the thrombosed (17.0\u00a0months, 95% CI: 13.7\u201320.3), though without significant difference (P\u2009=\u20090.148).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PD with MPV resection and reconstruction by FL is safe, feasible, and efficacious, it might provide a potential benefit for patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12893-020-01019-9","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T08:03:10Z","timestamp":1609747390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy\u2014cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Yi","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuancong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-8261","authenticated-orcid":false,"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"1019_CR1","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/bjs.1800811126","volume":"81","author":"JH Allema","year":"1994","unstructured":"Allema JH, Reinders ME, van Gulik TM, et al. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg. 1994;81:1642\u20136.","journal-title":"Br J Surg"},{"key":"1019_CR2","first-page":"154","volume":"223","author":"GM Fuhrman","year":"1996","unstructured":"Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreat Tumor Study Group Ann Surg. 1996;223:154\u201362.","journal-title":"Pancreat Tumor Study Group Ann Surg"},{"key":"1019_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.surg.2015.02.016","volume":"158","author":"R Amano","year":"2015","unstructured":"Amano R, Kimura K, Nakata B, et al. Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer. Surgery. 2015;158:191\u2013200.","journal-title":"Surgery"},{"key":"1019_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/SLA.0b013e31815aab22","volume":"247","author":"EF Yekebas","year":"2008","unstructured":"Yekebas EF, Bogoevski D, Cataldegirmen G, et al. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg. 2008;247:300\u20139.","journal-title":"Ann Surg"},{"key":"1019_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1499-3872(15)60400-3","volume":"14","author":"WL Wang","year":"2015","unstructured":"Wang WL, Ye S, Yan S, et al. Pancreaticoduodenectomy with portal vein\/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion. Hepatobiliary Pancreat Dis Int. 2015;14:429\u201335.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1019_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/SLA.0000000000000959","volume":"262","author":"S Dokmak","year":"2015","unstructured":"Dokmak S, Aussilhou B, Sauvanet A, Nagarajan G, Farges O, Belghiti J. Parietal peritoneum as an autologous substitute for venous reconstruction in hepatopancreatobiliary surgery. Ann Surg. 2015;262:366\u201371.","journal-title":"Ann Surg"},{"key":"1019_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijsu.2018.03.045","volume":"53","author":"Y Shao","year":"2018","unstructured":"Shao Y, Yan S, Zhang QY, et al. Autologous falciform ligament graft as a substitute for mesentericoportal vein reconstruction in pancreaticoduodenectomy. Int J Surg. 2018;53:159\u201362.","journal-title":"Int J Surg"},{"key":"1019_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/1457496916680944","volume":"106","author":"N Dusch","year":"2017","unstructured":"Dusch N, Lietzmann A, Barthels F, Niedergethmann M, R\u00fcckert F, Wilhelm TJ. International study group of pancreatic surgery definitions for postpancreatectomy complications: applicability at a high-volume center. Scand J Surg. 2017;106:216\u201323.","journal-title":"Scand J Surg"},{"key":"1019_CR9","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s11605-014-2549-6","volume":"18","author":"K Liao","year":"2014","unstructured":"Liao K, Wang H, Chen Q, Wu Z, Zhang L. Prosthetic graft for superior mesenteric-portal vein reconstruction in pancreaticoduodenectomy: a retrospective, multicenter study. J Gastrointest Surg. 2014;18:1452\u201361.","journal-title":"J Gastrointest Surg"},{"key":"1019_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jhbp.299","volume":"23","author":"RL Meniconi","year":"2016","unstructured":"Meniconi RL, Santoro R, Guglielmo N, et al. Pancreaticoduodenectomy with venous reconstruction using cold-stored vein allografts: long-term results of a single center experience. J Hepatobiliary Pancreat Sci. 2016;23:43\u20139.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1019_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.avsg.2019.11.008","volume":"65","author":"JL Pantoja","year":"2020","unstructured":"Pantoja JL, Chang K, Pellionisz PA, Woo K, Farley SM. Paneled saphenous vein grafts compared to internal jugular vein grafts in venous reconstruction after pancreaticoduodenectomy. Ann Vasc Surg. 2020;65:17\u201324.","journal-title":"Ann Vasc Surg"},{"key":"1019_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jvs.2009.09.025","volume":"51","author":"DY Lee","year":"2010","unstructured":"Lee DY, Mitchell EL, Jones MA, et al. Techniques and results of portal vein\/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy. J Vasc Surg. 2010;51:662\u20136.","journal-title":"J Vasc Surg"},{"key":"1019_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/hpb.12463","volume":"17","author":"MM Dua","year":"2015","unstructured":"Dua MM, Tran TB, Klausner J, et al. Pancreatectomy with vein reconstruction: technique matters. HPB (Oxford). 2015;17:824\u201331.","journal-title":"HPB (Oxford)"},{"key":"1019_CR14","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1007\/s11605-014-2635-9","volume":"18","author":"AN Krepline","year":"2014","unstructured":"Krepline AN, Christians KK, Duelge K, et al. Patency rates of portal vein\/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. J Gastrointest Surg. 2014;18:2016\u201325.","journal-title":"J Gastrointest Surg"},{"key":"1019_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/hpb.12205","volume":"16","author":"MD Chandrasegaram","year":"2014","unstructured":"Chandrasegaram MD, Eslick GD, Lee W, et al. Anticoagulation policy after venous resection with a pancreatectomy: a systematic review. HPB (Oxford). 2014;16:691\u20138.","journal-title":"HPB (Oxford)."},{"key":"1019_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","volume":"16","author":"O Strobel","year":"2019","unstructured":"Strobel O, Neoptolemos J, J\u00e4ger D, et al. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol. 2019;16:11\u201326.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-020-01019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12893-020-01019-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-020-01019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T08:19:36Z","timestamp":1609748376000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-020-01019-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1186\/s12893-020-01019-9","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"11 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. The committee\u2019s reference number is 2019\u20131496.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"For retrospective study formal consent is not required and the identities of the patients have been protected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}